Based on our observations that mutant PPM1D blocks this pathway via tumor-specific NAPRT silencing, NA supplementation may be an effective approach to further enhance the therapeutic index associated with NAMPT inhibition. The gene discussed is PPM1D; the disease is neoplasm.